Using older mice, scientists identified a key mediator of increased breast cancer metastasis, offering a potential ...
CPIX reports positive Phase 2a results for Ifetroban, showing a favorable safety profile and promising early signs of ...
A phase 2a trial suggests a potential breakthrough in cancer metastasis prevention, with fewer recurrences and no ...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, and Vanderbilt Health today announce data from a Phase 2a ...
Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior ...
Iza-bren improved survival and delayed disease progression versus chemotherapy in previously treated metastatic ...
A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that ...
Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results